Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bayerische Motoren Werke ADR (BMWYY)

Bayerische Motoren Werke ADR (BMWYY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 52,787,556
  • Shares Outstanding, K 1,807,793
  • Annual Sales, $ 168,296 M
  • Annual Income, $ 12,219 M
  • EBIT $ 18,075 M
  • EBITDA $ 27,787 M
  • 60-Month Beta 1.10
  • Price/Sales 0.31
  • Price/Cash Flow 2.31
  • Price/Book 0.52
  • Price/Earnings ttm 4.68
  • Earnings Per Share ttm 5.96
  • Most Recent Earnings $1.49 on 08/01/24
  • Next Earnings Date 11/06/24
  • Annual Dividend & Yield 1.56 (5.35%)
  • Most Recent Dividend 1.561 on 05/16/24
  • Sector Auto-Tires-Trucks
  • INDUSTRY GROUPING Auto - Foreign

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.1500 +16.10%
on 09/10/24
31.7700 -8.09%
on 08/27/24
-2.2800 (-7.24%)
since 08/26/24
3-Month
25.1500 +16.10%
on 09/10/24
33.5900 -13.07%
on 07/12/24
-2.1300 (-6.80%)
since 06/26/24
52-Week
25.1500 +16.10%
on 09/10/24
41.6500 -29.89%
on 04/04/24
-4.6600 (-13.76%)
since 09/26/23

Most Recent Stories

More News
Soligenix (NASDAQ: SNGX) Strengthens Financial Foundation to Advance Multiple Value Drivers

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases and biodefense programs, continues to fortify its financial position as it advances toward a series of pivotal...

SNGX : 1.3600 (-0.73%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma

Soligenix (NASDAQ: SNGX), a clinical-stage biotechnology company focused on rare diseases and public health solutions, has rejuvenated its U.S. Medical Advisory Board for cutaneous T-cell lymphoma (“CTCL”),...

SNGX : 1.3600 (-0.73%)
BMWYY : 29.2000 (+4.58%)
Nutriband (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, today announced it has received final meeting minutes from its Sept. 18, 2025, virtual meeting with the U.S. Food...

NTRB : 5.97 (-1.00%)
BMWYY : 29.2000 (+4.58%)
Nutriband (NASDAQ: NTRB) Partners with Brand Institute to Develop Global Brand Identity for AVERSA FENTANYL

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced that its subsidiary 4P Therapeutics has signed an agreement with Brand Institute, Inc., a global leader...

NTRB : 5.97 (-1.00%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Expands European Medical Advisory Board, Advances Phase 3 Study to Support HyBryte(TM) Development for CTCL

Cutaneous T-cell lymphoma (“CTCL”) is a rare but serious form of non-Hodgkin lymphoma that primarily affects the skin. Globally, millions suffer from CTCL, and in Europe, the annual incidence is estimated...

SNGX : 1.3600 (-0.73%)
BMWYY : 29.2000 (+4.58%)
Nutriband (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference

Nutriband (NASDAQ: NTRB) announced that Chairman Serguei Melnik will present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on Wednesday, Oct. 8, 2025, at 3 p.m. ET. The presentation...

NTRB : 5.97 (-1.00%)
BMWYY : 29.2000 (+4.58%)
Nuna and BMW Announce Exclusive Design Collaboration Highlighting Premium Quality and Unmatched Craftsmanship

/CNW/ - Nuna, the world-renowned authority in premium baby gear innovation, and BMW are delighted to announce an exclusive design collaboration. This...

BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Advances Psoriasis Trial with Encouraging Patient Results, Market Potential

Psoriasis remains a persistent challenge for millions of patients worldwide, and promising new treatments are being closely watched by the medical and investor communities alike. Soligenix (NASDAQ: SNGX),...

SNGX : 1.3600 (-0.73%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Strengthens Position in CTCL Treatment with HyBryte(TM) FLASH Results

Soligenix (NASDAQ: SNGX) is continuing to build momentum in its mission to advance HyBryte(TM), a first-in-class treatment for early-stage cutaneous T-cell lymphoma (“CTCL”). That progress is supported...

SNGX : 1.3600 (-0.73%)
BMWYY : 29.2000 (+4.58%)
Unity's New Trajectory: Why Its Stock Surge Is Built to Last

Unity's strategic pivot to AI-driven growth is fueling record cash flow and expanding its platform beyond gaming into high-value industrial markets.

U : 43.13 (+7.74%)
TCEHY : 83.5700 (+2.57%)
BMWYY : 29.2000 (+4.58%)
MBGAF : 67.5500 (-0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bayerische Motoren Werke AG develops, manufactures, and sells automobiles and motorcycles and spare parts and accessories. Bayerische Motoren Werke AG is based in Munich, Germany.

See More

Key Turning Points

3rd Resistance Point 29.5867
2nd Resistance Point 29.4333
1st Resistance Point 29.3167
Last Price 29.2000
1st Support Level 29.0467
2nd Support Level 28.8933
3rd Support Level 28.7767

See More

52-Week High 41.6500
Fibonacci 61.8% 35.3470
Fibonacci 50% 33.4000
Fibonacci 38.2% 31.4530
Last Price 29.2000
52-Week Low 25.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar